Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1426009Generated: November 1, 2026

(S)-6-(2-hydroxy-2-methylpropyl)-6-phenyl-3-((S)-1-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)ethyl)-1,3-oxazinan-2-one → 1-[6-(4-{(S)-1-[(S)-6-(2-Hydroxy-2-methyl-propyl)-2-oxo-6-phenyl-[1,3]oxazinan-3-yl]-ethyl}-phenyl)-pyridazin-3-yl]-cyclopropanecarbonitrile

https://huagongshe.com/reaction/1426009

Reaction equation

Participants

RoleNameHCIDCharge
Reactant(S)-6-(2-hydroxy-2-methylpropyl)-6-phenyl-3-((S)-1-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)ethyl)-1,3-oxazinan-2-oneHCID 59532385—
Reactant1-(6-Chloropyridazin-3-yl)cyclopropane-1-carbonitrileHCID 86696133—
Product1-[6-(4-{(S)-1-[(S)-6-(2-Hydroxy-2-methyl-propyl)-2-oxo-6-phenyl-[1,3]oxazinan-3-yl]-ethyl}-phenyl)-pyridazin-3-yl]-cyclopropanecarbonitrileHCID 5477084851%

Reaction Steps

The title compound was prepared from (S)-6-(2-hydroxy-2-methylpropyl)-6-phenyl-3-{(S)-1-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-ethyl}-1,3-oxazinan-2-one and 1-(6-chloro-pyridazin-3-yl)-cyclopropanecarbonitrile following a procedure analogous to that described in Example 1. Yield: 51% of theory; LC (method 2): tR=3.42 min; Mass spectrum (ESI+): m/z=497 [M+H]+.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS08933072B2
Source datasetuspto-grants-2015_01
ORD IDord-995c1945a7fd4fd7970426ad2a83ae26
Source noteuspto-grants-2015_01